Dr. Redman is a trained medical oncologist with deep expertise in translational research and early-phase clinical trials for solid tumors. Before joining K36, he led the Combination Immunotherapy Group at the Center for Immuno-Oncology at the National Cancer Institute.

​

His academic journey includes graduating cum laude with a B.S. in philosophy and biological sciences from the University of Connecticut, followed by earning his M.D. from New York Medical College. During medical school, he was awarded a research fellowship by Doris Duke Charitable Research Foundation which he completed at the University of Iowa’s Carver College of Medicine.

​

Dr. Redman went on to complete his internal medicine residency at Georgetown University Medical Center and a fellowship in medical oncology at the National Cancer Institute, where he was recognized as a Society for Immunotherapy of Cancer Fellow.